Search Page

1

Cite

Share

Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?

Mohamed-Hussein AAR, Aly KME, Ibrahim MAA. Mohamed-Hussein AAR, et al. Med Hypotheses. 2020 Nov;144:109975. doi: 10.1016/j.mehy.2020.109975. Epub 2020 Jun 8. Med Hypotheses. 2020. PMID: 32531536 Free PMC article. No abstract available.

Cite

Share

2

Cite

Share

Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism.

Haque S, Jawed A, Akhter N, Dar SA, Khan F, Mandal RK, Areeshi MY, Lohani M, Wahid M. Haque S, et al. Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9244-9245. doi: 10.26355/eurrev_202009_23005. Eur Rev Med Pharmacol Sci. 2020. PMID: 33015764 Free article. No abstract available.

Cite

Share

3

Cite

Share

Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?

Gavillet M, Rolnik DL, Hoffman MK, Panchaud A, Baud D. Gavillet M, et al. Ultrasound Obstet Gynecol. 2020 Jun;55(6):843-844. doi: 10.1002/uog.22063. Ultrasound Obstet Gynecol. 2020. PMID: 32349165 Free PMC article. No abstract available.

Cite

Share

4

Cite

Share

Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic.

Kwiatkowski S, Borowski D, Kajdy A, Poon LC, Rokita W, Wielgos M. Kwiatkowski S, et al. Ultrasound Obstet Gynecol. 2020 Jun;55(6):841-843. doi: 10.1002/uog.22049. Ultrasound Obstet Gynecol. 2020. PMID: 32304612 Free PMC article. No abstract available.

Cite

Share

5

Cite

Share

Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19.

Salah HM, Mehta JL. Salah HM, et al. Am J Cardiol. 2021 Mar 1;142:158-159. doi: 10.1016/j.amjcard.2020.12.073. Epub 2021 Jan 6. Am J Cardiol. 2021. PMID: 33417877 Free PMC article. No abstract available.

Cite

Share

6

Cite

Share

COVID-19 and Kawasaki Disease: Novel Virus and Novel Case.

Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, Nguyen EL, Barsh GR, Maskatia S, Mathew R. Jones VG, et al. Hosp Pediatr. 2020 Jun;10(6):537-540. doi: 10.1542/hpeds.2020-0123. Epub 2020 Apr 7. Hosp Pediatr. 2020. PMID: 32265235

The patient's initial echocardiogram was normal, and she was discharged within 48 hours of completion of her intravenous immunoglobulin infusion, with instruction to quarantine at home for 14 days from the date of her positive test results for COVID-19. Furth …

The patient's initial echocardiogram was normal, and she was discharged within 48 hours of completion of her intravenous immunoglobul …

Cite

Share

7

Cite

Share

Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.

Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Pavoni V, et al. Thromb Res. 2020 Dec;196:313-317. doi: 10.1016/j.thromres.2020.09.013. Epub 2020 Sep 13. Thromb Res. 2020. PMID: 32977129 Free PMC article.

BACKGROUND: Critically ill COVID-19 patients have a clear pattern of inflammation and hypercoagulable state. The main aim of the study was to evaluate the outcome of severe COVID-19 patients basing on prothrombotic risk factors (i.e. D-dimer). ...

BACKGROUND: Critically ill COVID-19 patients have a clear pattern of inflammation and hypercoagulable state. The main aim of t …

Cite

Share

8

Cite

Share

Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?

Bianconi V, Violi F, Fallarino F, Pignatelli P, Sahebkar A, Pirro M. Bianconi V, et al. Drugs. 2020 Sep;80(14):1383-1396. doi: 10.1007/s40265-020-01365-1. Drugs. 2020. PMID: 32705604 Free PMC article. Review.

Severe Acute Respiratory Syndrome-Coronavirus-2 is responsible for the current pandemic that has led to more than 10 million confirmed cases of Coronavirus Disease-19 (COVID-19) and over 500,000 deaths worldwide (4 July 2020). ...In addition, the poten …

Severe Acute Respiratory Syndrome-Coronavirus-2 is responsible for the current pandemic that has led to more than 10 million confirme …

Cite

Share

9

Cite

Share

SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients.

Sahai A, Bhandari R, Koupenova M, Freedman J, Godwin M, McIntyre T, Chung M, Iskandar JP, Kamran H, Aggarwal A, Kalra A, Bartholomew J, McCrae K, Elbadawi A, Svensson L, Kapadia S, Hariri E, Cameron S. Sahai A, et al. Res Sq. 2020 Dec 23:rs.3.rs-119031. doi: 10.21203/rs.3.rs-119031/v1. Preprint. Res Sq. 2020. PMID: 33398263 Free PMC article.

Coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral pandemic marked by increased risk of thrombotic events. ...Thus, while platelets clearly express ACE2-TMPRSS2 receptor-protease axis for SARS-CoV-2 …

Coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral pandemic marked by increased …

Cite

Share

10

Cite

Share

Mortality and pre-hospitalization use of low-dose aspirin in COVID-19 patients with coronary artery disease.

Yuan S, Chen P, Li H, Chen C, Wang F, Wang DW. Yuan S, et al. J Cell Mol Med. 2021 Jan;25(2):1263-1273. doi: 10.1111/jcmm.16198. Epub 2020 Dec 18. J Cell Mol Med. 2021. PMID: 33336936 Free PMC article.

To determine whether pre-hospitalization use of aspirin is associated with all-cause mortality in coronavirus disease 2019 (COVID-19) patients with coronary artery disease (CAD). ...There was no difference on in-hospital mortality between aspirin group …

To determine whether pre-hospitalization use of aspirin is associated with all-cause mortality in coronavirus disease 2019 (COVID …

Cite

Share